California 2023-2024 Regular Session

California Assembly Bill AB462

Introduced
2/6/23  
Refer
2/17/23  
Introduced
2/6/23  
Introduced
2/6/23  
Refer
2/17/23  
Refer
2/17/23  
Report Pass
3/2/23  
Refer
3/6/23  
Report Pass
3/2/23  
Report Pass
3/14/23  
Refer
3/6/23  
Refer
3/6/23  
Report Pass
3/14/23  
Refer
4/19/23  
Refer
3/14/23  
Refer
3/14/23  
Failed
2/1/24  
Refer
4/19/23  
Refer
4/19/23  
Failed
2/1/24  

Caption

Overdose response teams.

Impact

AB 462 reinforces and expands local health efforts by creating structured financial support for overdose response teams. Participating counties are mandated to report their activities annually to the Assembly Select Committee on Fentanyl, Opioid Addiction, and Overdose Prevention, thereby increasing accountability and providing a means to track progress. The bill aims to enhance cooperation between health and law enforcement agencies in the prevention and investigation of opioid-related incidents, potentially improving community health outcomes and safety. Given the rising rates of opioid overdoses, this legislation reflects an urgent response to a public health crisis.

Summary

Assembly Bill 462 seeks to address the ongoing opioid crisis in specific counties of California by establishing the Overdose Response Team Fund. This fund will enable local enforcement agencies in San Bernardino, Riverside, and Orange counties to create pilot programs that focus on overdose response efforts. The bill allows for the allocation of state grants to support the formation of overdose response teams specifically aimed at investigating fatal and nonfatal overdoses related to fentanyl, as well as those involving juveniles and multiple victims. The program is designed to run until January 1, 2029, providing a framework for local initiatives to combat overdose incidents effectively.

Sentiment

The sentiment surrounding AB 462 appears to be largely supportive, particularly among stakeholders in public health and law enforcement. Advocates for the bill argue that it recognizes the critical need for coordinated responses to the opioid crisis, praising its approach to combining health and safety efforts. However, there are concerns among some community members regarding the potential stigmatization of individuals struggling with addiction and whether law enforcement involvement may deter those in need from seeking help. Overall, the discourse highlights a desire for effective intervention strategies that balance public safety with compassionate care.

Contention

A notable point of contention revolves around the focus on law enforcement in addressing public health issues related to addiction. Critics raise questions about the appropriateness of involving sheriffs' departments in overdose response efforts, fearing it might lead to criminalization rather than health-focused solutions. The requirement for annual reporting on arrests and drug seizures can be perceived as a police-centric approach, which may conflict with the public health perspective aimed at harm reduction. Balancing these interests will be crucial as the bill moves forward and local governance implements the necessary programs.

Companion Bills

No companion bills found.

Similar Bills

CA AB1627

Opioid overdose prevention.

CA SB75

Controlled substances: fentanyl.

CA SB1395

Southern California Fentanyl Task Force.

CO HB1326

Fentanyl Accountability And Prevention

CA SB1161

Inland Empire Rural Crime Prevention Program.

NV SB35

Revises provisions relating to controlled substances. (BDR 40-423)

IA HF595

A bill for an act relating to controlled substances including the manufacture, delivery, or possession of a controlled substance including fentanyl; the manufacture of a controlled substance in the presence of a minor; conspiracy to manufacture for delivery or delivery or intent or conspiracy to deliver a controlled substance to a minor; receipt, provision, and administration of opioid antagonists, including by secondary distributors; providing for immunity; and providing penalties. (Formerly HSB 104.) Effective date: 07/01/2023.

IA SF508

A bill for an act relating to controlled substances including the manufacture, delivery, or possession of a controlled substance including fentanyl; the manufacture of a controlled substance in the presence of a minor; conspiracy to manufacture for delivery or delivery or intent or conspiracy to deliver a controlled substance to a minor; receipt, provision, and administration of opioid antagonists, including by secondary distributors; providing for immunity; and providing penalties.(Formerly SSB 1096.)